This review describes the development of ventilation using perfluorocarbon liquids, and relates the remarkable physical properties of these compounds to their probable mechanisms of action in clinical disease.
There has recently been much interest in the intensive care literature in the novel technique of liquid ventilation, in which the lungs are either partially or totally filled with perfluorocarbon liquid. This approach appears to confer significant benefit on the two major problems facing clinicians treating the acute and neonatal respiratory distress syndromes, namely hypoxaemia and low pulmonary compliance. In addition, there is evidence that lung injury may be moderated. The mechanisms of action of perfluorocarbon liquids are very similar to the effects of the recently advocated "open lung" strategy for ventilation in acute respiratory distress syndrome (ARDS).
CHARACTERISTICS OF PERFLUOROCARBONS
Perfluorocarbon liquids are simple organic compounds in which all the hydrogen atoms are replaced by halogens-either fluorine, bromine, or iodine. They are clear, colourless and odourless, and are insoluble in aqueous media. Perfluorocarbons have until recently been regarded as biologically inert, and do not appear to undergo significant metabolism.
The ability of perfluorocarbons to support tidal ventilation is dependent on their unique ability to dissolve both oxygen and carbon dioxide. This capacity to carry large amounts of oxygen has also led to the investigation of perfluorocarbons as blood substitutes, though no commercially available clinical product has yet emerged.
The two properties of perfluorocarbons which are crucial to their efficacy in clinical models of neonatal and acute respiratory distress syndromes are their high density and low surface tension. The density of perfluorocarbons is considerably greater than that of lung tissue, of the abdominal viscera, and of the proteinaceous exudate which fills the lungs in ARDS. They are therefore able to displace all these structures and substances, and this ability appears to be the main mechanism of benefit. The low surface tension of perfluorocarbons at a gas-liquid interface may be related to their action in improving pulmonary compliance in diseased lungs.
The perfluorocarbon which is currently undergoing clinical evaluation in liquid ventilation is perfluorooctyl bromide or perflubron. It is an eight-carbon molecule completely saturated with fluorine atoms except for a single terminal bromine atom, which confers the property of radio-opacity. Values for the relevant physical properties of perflubron are given in Table 1 .
HISTORY
For such an apparently novel technique, liquid ventilation has a surprisingly long history. In 1962, Kylstra, Tissing and van der Maen observed mice breathing spontaneously for hours in buffered Ringer's solution at eight atmospheres pressure 2 . Four years later, Kylstra published a description of the successful mechanical ventilation of dogs using hyperbarically oxygenated Ringer's solution 3 . The same year, Gollan and Clark reported that cats and mice were able to breathe in oxygenated fluorocarbon liquid sufficiently to survive many hours of immersion 4 . Initial interest in these findings centred around the possibility of preventing decompression sickness by using breathing of these non-compressible liquids to slow the diffusion of gases 5 . By 1970, Modell's group had shown that dogs were able to survive in the long term with no apparent sequelae after breathing perfluorocarbon liquid for eight hours 6 . In the same publication, Moskowitz proposed the viability of using perfluorocarbon liquid as a medium for mechanical ventilation 7 , and in 1973 Saga and Modell and colleagues reported the use of gravitational instillation and drainage of perfluorocarbon as a ventilatory medium in paralysed dogs 8 .
The technique of total liquid ventilation, in which both lungs and ventilator are filled with perfluorocarbon, represented a considerable engineering challenge, in view of the high density and viscosity of perfluorocarbons and the consequent low inspiratory and expiratory flow rates. In 1974, Shaffer and Moskowitz developed the first mechanical liquid ventilator 9 , a highly complex and specialized piece of equipment. Total liquid ventilation was applied by Shaffer first to healthy animals and then, in a series of pioneering experiments spanning more than a decade, to animal models of neonatal respiratory distress syndrome (neonatal RDS).
Early experiments with total liquid ventilation
The application of total liquid ventilation to healthy animals showed the technique to be possible. It was associated with a deterioration in oxygenation both during and after total liquid ventilation, and with a reduction in pulmonary compliance.
The next phase was the use of total liquid ventilation in animal models of neonatal RDS [10] [11] [12] [13] . Shaffer and his colleagues found the technique resulted in an increased arterial oxygen tension (PaO 2 ) and decreased alveolar-arterial oxygen tension difference (A-a DO 2 ). Concurrently, dynamic lung compliance increased, alveolar and peak tracheal pressures decreased, and inspiratory elastic work of breathing was reduced. Following drainage of the perfluorocarbon liquid and reversion to gas ventilation, the improvement in oxygenation and reduction in tracheal pressure persisted, in contrast to the effect seen in healthy animals. This was attributed to the effect of residual perfluorocarbon, with its low surface tension. The final finding in these studies was of marked attenuation in the post mortem histological injury in the liquid ventilated group compared with the gas ventilated controls.
Total liquid ventilation in models of ARDS
Relatively few studies have been performed of total liquid ventilation in models of ARDS as opposed to those of neonatal RDS. In collaboration with Shaffer, Hirschl and Bartlett's group from Ann Arbor, Michigan induced lung injury using a combination of oleic acid injection and saline lung lavage in sheep 14 .
The animals were then placed on veno-venous extracorporeal life support (ECLS), and subjected to either gas ventilation or total liquid ventilation. ECLS flows required to maintain adequate arterial oxygen tensions were markedly lower in the total liquid ventilation group, reflecting the expected improvement in oxygenation with this technique. This was shown to be due to a reduction in the physiological shunt fraction. In addition, pulmonary compliance was increased during total liquid ventilation. After completion of the experiment, the five liquid ventilation subjects all survived for one hour before being sacrificed, whereas the five gas ventilated controls all died within thirty minutes. Histological injury was attenuated in the total liquid ventilation group, with a marked reduction in alveolar haemorrhage, oedema and inflammatory infiltrate. In effect, these findings extended the previous results in neonatal models to a model of ARDS.
Partial liquid ventilation
The need for complex, specialized machinery has limited the attractiveness of total liquid ventilation for clinical use. The description in 1991 of partial liquid ventilation by Fuhrman, Paczan and De Francisis 15 represented a considerable practical advance. In this approach, the lungs of an intubated, ventilated subject are filled with a volume of perfluorocarbon liquid approximating the functional residual capacity, and conventional mechanical ventilation is resumed, using a standard ventilator at standard settings.
In healthy animals, Fuhrman found a small decrease in PaO 2 associated with the institution of partial liquid ventilation; thereafter oxygenation remained stable. Compliance was little changed. In the absence of any exogenous source of oxygen to the perfluorocarbon in the lungs, Fuhrman speculated that "in vivo bubble oxygenation" took place with tidal ventilation in order to explain the persistently good oxygenation observed. Further experiments in healthy animal models showed that adequate arterial oxygen tensions were obtained using inspired oxygen fractions as low as 0.3 16 , and that partial liquid ventilation could be sustained for up to 24 hours by repeated dosing with perfluorocarbon to replace evaporative losses 17 . Following this period, reversion to conventional gas ventilation was achieved without difficulty.
Partial liquid ventilation has been used in a number of models of both neonatal RDS and ARDS, including premature lambs with RDS 18 , saline lung-lavaged rabbits [19] [20] [21] and pigs 22 , and oleic acid injured dogs 23 and sheep 24 . A model of gastric aspiration has also been studied 25 . A finding common to all these studies has been the improvement in oxygenation and pulmonary compliance. Histological evidence of lung injury has also been shown to be attenuated by partial liquid ventilation in some 21, 24, 25 but not all 23 .
Tutuncu, Faithfull and Lachmann subjected twelve saline lung-lavaged adult rabbits to sequential intratracheal dosing with perfluorocarbon 19 . They found that airway resistance decreased and compliance increased after the first dose of perfluorocarbon, and did not change thereafter. PaO 2 , however, improved with each succeeding dose of perfluorocarbon. They concluded that the mechanism underlying the two changes must be different. This was supported by the observation that evaporative loss of perfluorocarbon caused a decay in the improvement in oxygenation, but had relatively little effect on the improvement in compliance.
Curtis 23 replicated the finding of dose-dependency in oxygenation during partial liquid ventilation of oleic acid injured dogs. However, he found an improvement in compliance only in those animals whose dose of perfluorocarbon corresponded to a volume less than two thirds of functional residual capacity. In contrast to all other studies examining this aspect, he found no histological evidence of attenuation of lung injury by partial liquid ventilation.
Nesti and colleagues used a model of gastric aspiration in which homogenized gastric aspirate, titrated to a pH of 1.0, was instilled into the tracheostomy tube of hitherto healthy anaesthetized piglets 26 . One hour after gastric aspirate instillation, partial liquid ventilation with perflubron was instituted in the treatment group, while the controls continued with gas ventilation. Over time, the gas ventilated group developed progressive hypoxaemia, whereas the partial liquid ventilation group remained fully saturated. Compliance was consistently and significantly greater in the latter group. At autopsy, there was minimal histological evidence of lung injury in the partial liquid ventilation group, in marked contrast to the gas ventilated controls. This has raised the possibility that perfluorocarbon administration may be useful in preventing the sequelae of human gastric acid aspiration.
Human studies of liquid ventilation
To date, relatively little has been published concerning human trials of liquid ventilation; the available reports are of small, uncontrolled phase I feasibility studies. Nonetheless, in the context of the extensive animal work that has gone before, these have been sufficiently encouraging that larger, controlled studies are presently under way.
The first report of human liquid ventilation was published in the Lancet in 1989 by Greenspan, Wolfson, Rubenstein and Shaffer 26 . They then reported the use of total liquid ventilation on a series of three neonates in whom death was judged to be imminent 27 . The infants all had neonatal RDS, having been born at gestational ages of 23, 24 and 28 weeks, and had proved refractory to all conventional therapeutic measures. These patients underwent two cycles of total liquid ventilation lasting three to five minutes each. The ventilator used was a simple gravityassisted device, which delivered tidal volumes of 15 ml/kg of perfluorocarbon at a frequency of two to three breaths per minute.
All three infants showed a marked improvement in total respiratory compliance, and two of the three also showed a marked improvement in oxygenation. These changes persisted into the recovery period, although all infants later deteriorated and died within nineteen hours of liquid ventilation. Autopsies were performed in two of the patients, and the findings were consistent with hyaline membrane disease and pronounced pulmonary immaturity.
This was the first and is to date the only reported use of total liquid ventilation in humans. The improvements seen were those expected from animal work on neonatal RDS models, namely of increased oxygenation and compliance. The period of total liquid ventilation was well tolerated and not associated with any haemodynamic deterioration.
There have been three other reports, all from Ann Arbor, Michigan, of the use of partial liquid ventilation in five neonates, six non-neonatal paediatric patients and ten adults [28] [29] [30] . All patients were already requiring ECLS, for which this institution appears to have a policy of early implementation.
Partial liquid ventilation was initiated by instilling aliquots of 2.5 to 10 ml/kg of perflubron over 5 to 15 minutes, and repeating the dose every thirty minutes until a meniscus was visible within the endotracheal tube at the level of the sternum. Thereafter, re-dosing with perfluorocarbon took place on a daily basis depending on radiographic assessment of the amount of perfluorocarbon remaining in the lungs, the presence or absence of a meniscus within the endotracheal tube, and the likelihood or otherwise of imminent weaning from ECLS. Dosing continued for a period of up to seven days, with a mean cumulative dose of 36.3 ml/kg of perflubron.
Outcome measures were weight-corrected pulmonary compliance and either the A-a DO 2 or the calculated physiological shunt fraction measured at the end of a short period of withdrawal of ECLS, during which the patients were ventilated in a standardized fashion.
The results from these studies have been published in three articles, the first being a preliminary communication in the Lancet of data from the neonates, the adults and four of the children 28 . This report showed improvements in compliance and A-a DO 2 after three days of partial liquid ventilation that were highly significant, both statistically and clinically. Compliance improved from 0.18 to 0.29 ml/cm H 2 O/kg (P=0.0002), and A-a DO 2 from 590 to 471 mmHg. Of the nineteen patients, fourteen were successfully weaned from ECLS; eleven were discharged from hospital, and remained well when reviewed between two and twelve months later.
Data from all six paediatric patients were published separately 29 ; again the endpoints reported were the weight-corrected pulmonary compliance and the A-a DO 2 . Trends in these measurements towards improvement did not quite reach statistical significance, though the authors point out that this may have been due to small sample size.
A similar situation is seen in the separately reported adult data 30 . Here the outcome measures were weight-corrected compliance and calculated physiological shunt fraction, again measured off ECLS, reported daily for three days. The improvement in shunt fraction was significant when analysed as the difference between values from before and after the whole period of partial liquid ventilation, but not when analysed as a day-to-day difference. The observed improvement in compliance gave similar results when analysed for significance. That the initial report of nineteen patients showed highly significant results may have been due to the larger sample size. However, it is also possible that the timing of initial treatment is important. It seems likely that the human patients were treated with partial liquid ventilation rather later in the course of the disease than were the animal models.
The only potentially adverse events were one pneumothorax in the adult group and two in the paediatric group, and one episode of mucus plugging which cleared with bronchoscopy. The authors observed that the radiographic delineation of collapsed lung and of small pneumothoraces was increased during partial liquid ventilation, making the diagnosis of these conditions more likely. Although the tips of intravascular catheters were obscured in some films taken soon after initial dosing with perfluorocarbon, this was not felt to be a significant problem.
These were uncontrolled studies, and whilst broadly encouraging, cannot be interpreted as proving a benefit from partial liquid ventilation.
PATHOPHYSIOLOGY OF ARDS
The early, exudative stage of ARDS is characterized by neutrophil activation, margination and extravasation into the pulmonary interstitium, causing increased capillary permeability and proteinaceous pulmonary oedema. This increase in capillary permeability has recently been shown to be uniformly distributed throughout the lung 31 . The second, fibroproliferative phase follows some three to five days later, with the appearance of an increase in type II pneumocytes, fibrosis and capillary obliteration.
Gattinoni's discovery that the increase in lung tissue density seen in ARDS on frontal chest X-ray is not uniformly distributed, in contrast to the increased capillary permeability, has had far-reaching implications. Between 1987 and 1993, his group in Milan reported a series of studies using computerized tomography (CT) to measure regional lung density and observe its relationship to gas exchange, volumepressure curves and various therapeutic manoeuvres such as application of positive end-expiratory pressure (PEEP) and prone positioning [32] [33] [34] [35] . Their findings may be summarized as follows: 1. Lung tissue density increases from ventral to dorsal regions in supine subjects. The lung could be viewed as comprising three zones, corresponding to well aerated, poorly aerated and non-aerated tissue. 2. Total respiratory system compliance correlates with the mass of well aerated tissue; the specific compliance of this zone was normal. This implies that the reduction in lung compliance seen in ARDS is due to the reduction in the amount of lung tissue available for ventilation-the "baby lung" concept. 3. PEEP resulted in a decrease in the calculated physiological shunt fraction, and this correlated with recruitment of unventilated tissue into the well aerated zone. 4. The level of PEEP required to recruit any given tissue plane within the lung was close to: (i) the hydrostatic pressure which it was calculated that the overlying lung tissue subtended to that plane, (ii) the pressure at the inflection point of that plane's volume-pressure curve. The inflection point in the volume-pressure curve of the total respiratory system was identified by Matamis and Lemaire 36 , and is thought to represent the pressure at which maximal recruitment has occurred, and above which further increases in pressure result only in distension of already recruited tissue. 5. Prone positioning resulted in the redistribution of increased density to the newly dependent anterior regions within ten minutes. The implications of this elegant work are that: 1. In ARDS, the lung behaves as an elastic body, with the increased tissue density causing an exaggeration of the compression atelectasis normally seen in dependent regions of the lung. 2. The optimal value of PEEP represents a compromise value which maximally recruits collapsed dependent tissue whilst avoiding overdistension of ventilated, non-dependent tissue. 3. The use of "normal" tidal volumes in ARDS is inappropriate for the volume of lung tissue to which gas is distributed, and may therefore cause overdistension. This and other work has provided the theoretical basis for the search for a lung protective strategy for ventilation in ARDS. It has long been recognized that mechanical ventilation is capable of exacerbating and even causing lung injury. The mechanisms underlying these changes appear to be: 1. Oxygen toxicity. 2. Overdistension of lung tissue to above the total lung capacity for that region. This may be due either to excessive peak inspiratory volume or to an excessive excursion in inspiratory pressure, and may result in either of the two effects described below 37-39 . 3. Collapse/re-expansion injury was described by Muscedere et al 40 in a study of rats ventilated at low levels of PEEP. An acute lung injury developed which was attributed to shear stress caused by tidal collapse and re-expansion of small airways. 4. Prolonged collapse has been postulated to result in tissue hypoxia, failure to clear secretions and possibly parenchymal infection. Gattinoni has suggested that this process may underlie the bullous change which he observed in dependent regions of the lungs in the later stages of ARDS 38 . The important effects are: 1. Air leak syndrome, in which unsupported alveoli near respiratory bronchioles rupture, permitting air to track along the peribronchial planes and leak into inappropriate compartments-pleural space, mediastinum, peritoneum etc. The incidence is related to overinflation by both excessive peak inspiratory volume and by excessive inspiratory pressure excursion [37] [38] , as well as to the underlying pulmonary pathology. 2. A parenchymal lung injury, with alveolar haemorrhage and oedema formation, which closely resembles the changes of ARDS. This has been associated with pulmonary oxygen toxicity, overinflation by both volume and pressure excess, and collapse/re-expansion. Influenced by these considerations and Gattinoni's findings, Amato and colleagues 41 recently reported a technique of ventilation involving: 1. Maintenance of PEEP levels above the lower inflection point of the volume-pressure curve. 2. Pressure limiting to below 40 cm H 2 O.
Low tidal volumes (<6 ml/kg).
This "open lung" strategy was designed to avoid tidal opening and closing of airways and to recruit dependent, collapsed alveoli, whilst avoiding overdistension. The control group was ventilated according to what the authors described as a conventional technique with PEEP minimized; however normocapnia was maintained, and the tidal volumes used were large (12 ml/kg). Although they were unable to show any survival benefit, this may have been due to three deaths in the "open lung" group from unrelated causes following successful weaning but before hospital discharge. On the other hand, a highly significant benefit in terms of oxygenation and compliance was shown over several days, and an improvement in the rate of successful weaning was significant at the 5% level.
This study has been widely accepted as showing the first controlled evidence of benefit, at least in terms of pulmonary function and weaning, if not of survival, from an alternative strategy of positive pressure ventilation. There is now an emerging consensus that recruitment of collapsed tissue and the avoidance of high pressures and tidal volumes represent desirable and beneficial goals in ventilating patients with ARDS 42 . It is precisely these goals which liquid ventilation achieves.
MECHANISMS OF ACTION
The mechanisms whereby liquid ventilation exerts beneficial effects on oxygenation, pulmonary compliance and possibly on the pathology of lung injury itself, are complex and only partially elucidated.
Oxygenation
It is clear from both animal 14, 24, 43 and human data 30 that liquid ventilation is capable of reducing the physiological shunt fraction. This in turn improves systemic arterial oxygen tensions and alleviates the hypoxaemia associated with ARDS and neonatal RDS and their animal models. Two related mechanisms have been proposed whereby physiological shunt may be reduced during liquid ventilation.
Recruitment
The major part of the benefit to oxygenation of liquid ventilation is likely to derive from its ability to recruit hitherto collapsed, non-aerated tissue into the ventilated portion of the lungs, as Gattinoni has shown that PEEP does. This ability stems from the high density of perfluorocarbon liquids, which exceeds that of oedematous lung tissue and of the abdominal contents. Perfluorocarbon liquids are thus able to displace these structures, overcoming the compressive effects of the overlying lung and the abdominal viscera on dependent regions of the lung. This causes preferential filling by perfluorocarbon of the dependent regions, recruiting them into the ventilated portion of the lung.
The evidence for this mechanism is as follows: 1. Tutuncu, Faithfull and Lachmann's observation that improvements in arterial oxygen tension were dose-dependent and decayed with time implies that the mass of perfluorocarbon present within the lung is the relevant factor 19 . 2. CT density studies performed during total liquid ventilation have shown that, in contrast to Gattinoni's findings during gas ventilation, there is a uniform distribution of the ventilatory medium 43 . This implies recruitment of dependent regions. 3. Chest X-ray appearances and CT density studies during partial liquid ventilation show a dependent distribution of perfluorocarbon 44, 45 . 4. D'Angelo and Agostoni found that, in contrast to the air-filled lung, when the in vivo lung was filled with perfluorocarbon the alveolar distending or transpulmonary pressure was greatest in dependent rather than the non-dependent parts of the lung 46 . This gravitational effect of perfluorocarbon on recruitment has been compared favourably with that of PEEP by Hirschl, who described perfluorocarbon as '"PEEP in a bottle" that is more specifically directed to the dependent parts of the lung and more effective than the PEEP that we typically administer with gas' 43 .
Redistribution of perfusion
Shunt reduction during liquid ventilation could theoretically result from redistribution not only of ventilation, but also of perfusion. The effects on the pulmonary circulation of introducing a high density medium into the lung were investigated by Lowe and Shaffer 47 . They found that there was an increase in pulmonary vascular resistance when the unventilated, perfused lung was filled with perfluorocarbon. They also found that the pulmonary blood flow was redistributed towards non-dependent regions. However the size of this effect was small; the proportion of total pulmonary blood flow reaching the least dependent quarter of the lung increased on filling with perfluorocarbon from 14% to 18%. These changes in blood flow and vascular resistance were attributed to compression of the pulmonary vasculature by the high density perfluorocarbon, an effect which would naturally be greatest in dependent tissue.
The occurrence of redistribution of perfusion during partial liquid ventilation has been confirmed in two abstract publications 48, 49 . One of these also examined the effect of this change on the observed shunt, and although it purported to show that redistribution of perfusion was responsible for a reduction in shunt, no data were given to exclude the possibility that redistribution of ventilation (i.e. recruitment) was in fact the mechanism involved. Thus, whilst pulmonary blood flow redistribution certainly occurs in partial liquid ventilation, it has not been proved to exert beneficial effects on oxygenation.
Compliance
An increase in pulmonary compliance has been a constant observation in animal work on liquid ventilation [9] [10] [11] [12] 14, [18] [19] [20] [21] [23] [24] [25] 43 and it appears that it also occurs when the technique is applied to humans [27] [28] [29] [30] . The mechanism of this is unclear.
Kylstra and Schoenfisch 50 showed that the elastic recoil of a fluorocarbon-filled lung, whilst appreciably higher than that of a lung filled with saline, was still greatly reduced in comparison with the air-filled healthy lung. They concluded that the alveolarperfluorocarbon interface possessed significant surface tension, but that this was much lower than that of the alveolar-air interface. In total liquid ventilation, it is therefore likely that compliance is improved by the abolition of the diseased alveolar-air interface and its replacement with a diseased alveolarperfluorocarbon interface, with a lower elastic recoil.
This mechanism cannot be so easily invoked to explain the observed increase in pulmonary compliance seen during partial liquid ventilation of the injured lung. In this case there are two main possibilities: 1. Recruitment of collapsed lung tissue will increase the size of the ventilated region of the lung. Since Gattinoni found that pulmonary compliance in ARDS was a function of the mass of normally aerated tissue, it follows that expanding the ventilated portion of the lung should improve the compliance of the total respiratory system. 2. Lachmann has postulated that a thin film of perfluorocarbon is distributed throughout the lung, independently of the gravitational distribution of the majority of the fluid 1, 19 . According to this theory, the low surface tension of perfluorocarbon will reduce lung elastic recoil and improve compliance.
Against the first possibility is Lachmann's observation during partial liquid ventilation that the improvement in compliance, in contrast to that in oxygenation, was not a dose-dependent phenomenon 19 . His conclusion was that recruitment was therefore unlikely to be responsible for changes in compliance. There appears to be no direct evidence for his theory of a perfluorocarbon film; its viability depends on the relative surface tensions of perfluorocarbon (18 dyn/cm in the case of perflubron) and the alveolar-air interface in ARDS. This is likely to be highly variable. It has been suggested that the action of perfluorocarbon in increasing compliance is that of an "exogenous surfactant" (discussion following reference 43). Clearly this cannot be the case-surfactant's unique ability to vary its surface tension as a function of its surface area is in contrast to the low but constant surface tension of perfluorocarbons. Nonetheless, the feasibility of Lachmann's suggestion may be indirectly supported by the finding 51 of a minimum surface tension of surfactant from ARDS patients of 29 dyn/cm.
At present there is evidence in support of both hypotheses, and the mechanism of improved com-pliance during partial liquid ventilation in ARDS remains uncertain.
Protection against lung injury
A number of studies have suggested that liquid ventilation is capable of protecting against the development of lung injury, or of attenuating its severity 13, 14, 24, 25, 43 . One study sought this action and failed to find it in an oleic acid injured canine model 23 . Various mechanisms have been proposed: 1. Protection against ventilation-induced lung injury, by recruitment of atelectatic regions and protection against high airway pressures and overdistension. This is supported by the functional similarity between partial liquid ventilation and the lung protective strategy described by Amato et al. However there is no direct histological evidence of a benefit to lung injury of the "open lung" approach. Recruitment of dependent areas may also prevent their exposure to hypoxic conditions for long periods. Such exposure has been proposed by Gattinoni to be responsible for the bullous change he observed in these areas in late ARDS 37 . No animal studies of liquid ventilation have examined this possibility. Also, Finfer's group was unable to replicate Gattinoni's findings; their subjects developed bullae in anterior, non-dependent regions 50 . Finfer speculated that this may have been due to alveolar overdistension. It may therefore be that protection of anterior areas from ventilationinduced injury by the use of partial liquid ventilation will nonetheless prove to minimize this bullous change. However, it seems unlikely that protection against ventilator-related damage represents the whole source of the benefit of liquid ventilation. 2. Displacement of alveolar oedema and its lavage from the lung by the denser perfluorocarbon may cause the removal of inflammatory mediators and other molecules involved in lung injury (e.g. elastase, reactive oxygen species). Such a lavage process has been commonly described during liquid ventilation 29, 30 . There appear to be no data investigating the direct relevance of this phenomenon to attenuation of lung injury, although Papo et al 53 have discounted the possibility that removal of proteinaceous oedema may protect surfactant against the damage that is known to incur from this source. 3. A specific anti-inflammatory action of perfluorocarbon has also been postulated. Smith et al 54 obtained alveolar macrophages from rabbits and piglets by lung lavage, and exposed one group to perfluorocarbon. They assessed the production of oxygen-derived free radicals by chemiluminescence and hydrogen peroxide assay, and found a significant reduction of both in macrophages exposed to perfluorocarbon. They concluded that exposure to perfluorocarbon inhibited macrophage production of molecules involved in the process of lung injury. 4. Increased surfactant production may mitigate the injury process. There is some evidence that liquid ventilation may stimulate surfactant production 55, 56 . Surfactant appears to be involved in some antiinflammatory mechanisms within the lung although its precise role is far from clear. Both stimulatory and inhibitory effects of surfactant on alveolar macrophages have been reported 57 .
SAFETY OF PERFLUOROCARBONS Ventilation
Concerns regarding the safety of intratracheal administration of perfluorocarbon have centred on five main areas. 1. Pulmonary function. The effects on lung function vary with the state of the recipient lung. In healthy lungs, a transient deterioration in compliance, functional residual capacity 8 , and oxygenation 6, 17 has been observed following liquid ventilation. The hypoxaemia required only low levels of PEEP for correction. In lung injury models, on the other hand, there has been a transient improvement in these parameters compared with the period prior to liquid ventilation 10, 11 . Both these changes have been attributed to the presence of residual quantities of perfluorocarbon. 2. Surfactant function. Lachmann has speculated that there may be a deleterious effect on the surfactant system of healthy lung 1 . The surfactant response to lavage with perfluorocarbon was studied by Modell 58 who investigated the characteristics of canine pulmonary surfactant after exposure to perfluorocarbon in vitro and in vivo. He found no abnormalities. However, Tutuncu et al recently reported increased 99mTc -DTPA clearance from lung in healthy rabbits subjected to partial liquid ventilation compared with gas ventilated controls 59 . This increased tracer clearance has been shown in previous work to be a marker for changes in pulmonary surfactant. The effect was no longer noticeable after seven days. Whilst liver phosphatidylcholine production has been shown to be reduced following liquid ventilation 60 , recent data presented in abstract form suggests that type II pneumocyte production of phosphatidylcholine is actually enhanced by liquid ventilation in both healthy and distressed neonatal lungs 55, 56 . There would there-fore seem to be little evidence of deleterious effects on the pulmonary surfactant system. 3. Haemodynamic response. Concern in this regard stems from early reports of reduction in cardiac output and development of metabolic acidosis during liquid ventilation 10, 11, 20, 21 . This has not been a universal finding 16 , and seems to be correctable with moderate volume loading 61 . It has been attributed to increased right ventricular afterload resulting from compression by perfluorocarbon of the pulmonary vasculature. Whilst this has been shown to occur in the unventilated, perfused lung by Shaffer and Lowe 47 , a study by Lachmann's group designed specifically to address this difficulty in large animals found no effect of partial liquid ventilation 22 . They observed no change in pulmonary vascular resistance during partial liquid ventilation of large adult pigs with lavage-induced lung injury, and postulated that this may have been due to relief of hypoxic pulmonary vasoconstriction by the superior oxygenation achieved with partial liquid ventilation. It is also possible that the smaller weight of perfluorocarbon used in partial liquid ventilation has less effect than the larger amounts required to fill the lung completely. 4. Histological injury. Early histological studies 62 using the perfluorocarbons FX-80, FC-75, FC-43, and the silicone oil DC-200 in healthy lungs revealed a wide variation in the histological response to the different agents. Changes observed included diffuse inflammatory change, with focal atelectasis and alveolar oedema and haemorrhage. Agent-specific changes consisted of widening of perivascular spaces with FX-80 (a change similar to that seen in drowning), and macrophage infiltration with FC-75 and FC-43. These compounds are not currently undergoing clinical evaluation for liquid ventilation. The only medical grade perfluorocarbon, perfluoro-octyl bromide or perflubron 63 , has not been associated with any deleterious histological effect on the lung, with the exception of a single abstract report of the formation of perivascular cuffs in rabbits 64 . 5. Systemic absorption. Longterm survival in apparently perfect health following liquid ventilation has been observed in a number of species including humans 28 . Calderwood and colleagues studied a group of dogs for up to three years after liquid ventilation 65 . Although they found trace amounts of perfluorocarbon in all tissues studied, there were no significant histological changes associated with this. Apart from a brief elevation in serum alkaline phosphatase, serum cholesterol, and white blood cell count which lasted less than a week, they saw no deleterious effects from liquid ventilation. Another canine study has shown low serum levels of FX-80 during liquid ventilation 66 . This finding of low level but appreciable uptake of perfluorocarbon with no discernible adverse effect has been replicated in adult humans, in whom minimal amounts of perfluorocarbon remained visible on follow-up chest X-rays up to four months after undergoing therapeutic partial liquid ventilation 44 . The only primate study 67 found trace tissue levels of perfluorocarbon in adult monkeys three years after they had been subjected to liquid ventilation. Again, no clinical or macroscopic abnormalities were apparent. Human neonates also appear to have absorbed small amounts of perfluorocarbon during liquid ventilation, as evidenced by the detection of low blood and tissue levels 68 .
Intravenous administration
Interest in the intravascular use of perfluorocarbons stemmed from their potential role in artificial oxygenation of blood or as substitutes for transfused blood. A number of problems have been reported including acute right heart failure from multiple pulmonary platelet microemboli, perfluorocarbon foam formation, permeability pulmonary oedema and pulmonary haemorrhage 69, 70 . However perfluorocarbon emulsion preparations such as Fluosol DA have been safely used as blood transfusion substitutes in large clinical trials in humans 71 . The problems of thrombogenesis and foaming have not been reported following liquid ventilation.
No adverse reactions have been reported following the use of perflubron as an oral contrast medium for gastro-intestinal radiology, from intravascular administration or from subcutaneous injection for indirect lymphangiography 44, 72 .
CONCLUSIONS
Partial liquid ventilation acts primarily by gravitational recruitment of collapsed lung units, and possibly by reducing surface tension at the diseased alveolar-air interface. Thus it may be seen as a means of recruiting and mechanically protecting the lung against the deleterious effects of positive pressure ventilation. It is therefore strikingly similar in its actions to the alternative ventilatory strategies involving lung recruitment with PEEP and protection from overdistension and the effects of repeated collapse and re-expansion. It has shown great promise in preliminary animal studies, and is known to be applicable to human ARDS. Whilst early reports of liquid ventilation using perfluorocarbons have contained some evidence of adverse responses, these do not appear to be significant in recent trials in acute lung injury models using perflubron. In particular, there is little evidence of an adverse effect on the pulmonary surfactant system. Although animal studies have shown persistent tissue uptake of perfluorocarbons following liquid ventilation, this has not been associated with significant metabolic, biochemical, haematological or histological complications. Finally, the agent currently undergoing clinical evaluation, perflubron, appears to have a good safety profile.
Areas currently being investigated include: 1. Larger phase II/III human randomized, controlled trials examining outcome in terms of ventilatorfree days and mortality as well as physiology are presently in progress. These studies are randomizing patients with isolated respiratory failure, and their results will clearly play a major part in determining the role of partial liquid ventilation in clinical practice. However, it is unclear whether any improved survival in isolated respiratory failure related to ARDS will also be seen in the more common patients with multiple organ dysfunction syndrome. Estimates of the proportion of patients with ARDS dying from isolated respiratory failure rather than multiple organ failure vary between 20% and 50%. 2. Mechanisms of attenuation of lung injury are the focus of considerable interest, in view of the exciting possibility that reduction of inflammation within the lung may in some cases diminish the systemic inflammatory response. This holds out hope of benefit to the majority of patients for whom multiple organ failure is the cause of death. 3. The relevance of redistribution of perfusion in producing a reduction in physiological shunt fraction remains to be clarified, as does the mechanism of improvement in compliance.
Other areas of interest include the optimum dose of perfluorocarbon (a question analogous to the "best PEEP" debate), the stage of clinical disease at which most benefit accrues, the extent to which the injured human lung permits systemic uptake of perfluorocarbon and the clinical consequences, if any, of this.
At present, partial liquid ventilation remains an unproven technique, but it seems likely to permit ventilatory support in severe cases of ARDS refractory to conventional ventilation. It is possible that early use of partial liquid ventilation in less severe cases may further inhibit the inflammatory response, thereby improving outcome. Thus partial liquid ventilation may not remain the province of a few specialized units dealing with highly refractory disease, but may instead find its way into the mainstream of clinical practice.
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